Pharmacological Management of Chemotherapy-Induced Nausea and Vomiting in Children with Cancer

被引:11
作者
Cefalo, M. G. [1 ]
Ruggiero, A. [1 ]
Maurizi, P. [1 ]
Attina, G. [1 ]
Arlotta, A. [1 ]
Riccardi, R. [1 ]
机构
[1] Univ Cattolica Sacro Cuore, Div Pediat Oncol, I-00168 Rome, Italy
关键词
Nausea; vomiting; chemotherapy; children; antiemetic agents; MODERATELY EMETOGENIC CHEMOTHERAPY; CISPLATIN-INDUCED EMESIS; ANTIEMETIC THERAPY; DOUBLE-BLIND; NEUROKININ-1; ANTAGONIST; PEDIATRIC ONCOLOGY; PHASE-III; APREPITANT; PREVENTION; ONDANSETRON;
D O I
10.1179/joc.2009.21.6.605
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Nausea and vomiting are respectively the first and third most relevant chemotherapy-associated side effects in pediatric oncology, despite the introduction of new antiemetic agents. Symptoms change according to the antineoplastic agents used, and are influenced by age since emotional and psychological aspects play an important role. Studies conducted on new antiemetic therapies usually focus on adult populations affected by tumors, whereas there are very few series including pediatric patients, who are even more severely affected by this specific side effect.
引用
收藏
页码:605 / 610
页数:6
相关论文
共 50 条
  • [31] Rolapitant for the treatment of chemotherapy-induced nausea and vomiting
    Navari, Rudolph M.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2015, 15 (10) : 1127 - 1133
  • [32] Protective effect of aprepitant against chemotherapy-induced nausea and vomiting in postoperative chemotherapy for gastric cancer
    Sun, Ning
    Zhang, Yan
    Li, Chenchen
    Wang, Xiaoming
    Guo, Renhong
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2019, 18 (08) : 1697 - 1703
  • [33] Delayed Chemotherapy-Induced Nausea and Vomiting: Pathogenesis, Incidence, and Current Management
    Rapoport, Bernardo L.
    FRONTIERS IN PHARMACOLOGY, 2017, 8
  • [34] Safety evaluation of aprepitant for the prevention of chemotherapy-induced nausea and vomiting
    Ruhlmann, Christina H.
    Herrstedt, Jorn
    EXPERT OPINION ON DRUG SAFETY, 2011, 10 (03) : 449 - 462
  • [35] Acute chemotherapy-induced nausea and vomiting in children with cancer: Still waiting for a common consensus on treatment
    Ruggiero, Antonio
    Rizzo, Daniela
    Catalano, Martina
    Coccia, Paola
    Triarico, Silvia
    Attina, Giorgio
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2018, 46 (06) : 2149 - 2156
  • [36] Clinical Predictors of Chemotherapy-induced Nausea and Vomiting in Breast Cancer Patients Receiving Adjuvant Doxorubicin and Cyclophosphamide
    Shih, Vivianne
    Wan, Hee Siew
    Chan, Alexandre
    ANNALS OF PHARMACOTHERAPY, 2009, 43 (03) : 444 - 452
  • [37] The effect of palonosetron hydrochloride in the prevention of chemotherapy-induced moderate and severe nausea and vomiting
    Huang, Jian
    Wang, Xiao-Jia
    Yu, Ding
    Jin, Ye-Ning
    Zhen, Lei-Zhen
    Xu, Nong
    Liu, Wei
    Deng, Yong-Chuan
    Wu, Shi-Xiu
    He, Jia
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2013, 5 (05) : 1418 - 1426
  • [38] Chemotherapy-Induced Nausea and Vomiting in the Treatment of Gastrointestinal Tumors and Secondary Prophylaxis with Aprepitant
    Abbrederis, Kathrin
    Lorenzen, Sylvie
    Rothling, Nadine
    Ihbe-Heffinger, Angela
    Schuster, Tibor
    Peschel, Christian
    Lordick, Florian
    ONKOLOGIE, 2009, 32 (1-2): : 30 - 34
  • [39] Adherence to pediatric acute chemotherapy-induced nausea and vomiting guidelines in Canadian hospitals
    McKinnon, Krista
    Jupp, Jennifer
    Ghosh, Sunita
    Digout, Carol
    Eason, Stephanie
    Romanick, Marcel
    PEDIATRIC BLOOD & CANCER, 2019, 66 (01)
  • [40] Update on the management of chemotherapy-induced nausea and vomiting - focus on palonosetron
    Zhou, Michelle
    Popovic, Marko
    Pasetka, Mark
    Pulenzas, Natalie
    Ahrari, Soha
    Chow, Edward
    DeAngelis, Carlo
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2015, 11 : 713 - 729